Daoyinyangshengshu

2 papers4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

2 independent labs in 1 country

Outcomes

Diastolic blood pressure

downin humans1

1 study

Daoyinyangshengshu decreases diastolic blood pressure in humans (SMD = -1.26, 95 % CI [-1.65, -0.87]).
“Daoyinyangshengshu was the most effective in improving diastolic blood pressure (SMD = -1.26, 95 % CI [-1.65, -0.87])”
Reviewhypertension
Effects of six traditional Chinese mind-body exercise therapies on vascular health and cardiac function in middle-aged and elderly hypertensive patients: A network meta-analysis of 48 randomized controlled trials
Ageing research reviews29 Dec 2025

Latest

1 in 12 months

Ageing Research Reviews1 Jan

Effects of six traditional Chinese mind-body exercise therapies on vascular health and cardiac function in middle-aged and elderly hypertensive patients: A network meta-analysis of 48 randomized controlled trials

Meta-analysis of randomised trialsHypertension

Paper

iScience15 May

Effects of six Chinese mind-body exercise therapies on glycolipid metabolism and vascular endothelial function in hypertensive patients

Meta-analysis of randomised trialsMind-body exercise